Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO
Eli Lilly has been on a deal-making spree in recent years in a bid to increase products and sales in core franchises as older…
Author
Piramal divests its DRG Business for $950 million
PEL had initially invested US$650 Million in 2012 to acquire DRG out of which $260 Mn was infused as equity
Hilleman Laboratories to develop a novel vaccine against Group B Streptococcus
Hilleman Laboratories also announced plans to venture into the area of maternal and child health
Indian Society for Clinical Research to host 13th Annual Conference in Mumbai
Leading up to the annual conference, six pre-conference workshops have been scheduled for clinical researcher professionals,…
Strides receives US FDA approval for Loratadine OTC Softgel Capsules
The product is a generic version of Claritin Liqui-Gels Capsules, 10 mg, of Bayer HealthCare LLC
Lonza India plans to double its turnover by 2024
Lonza is a global integrated solutions provider for pharma, consumer healthcare and nutrition segments. Deepak Sood, MD, Lonza…
ANDA approvals in 2019: Trends for the generics industry
Meenu Grover Sharma, Scholar Delhi Pharmaceutical Sciences & Research University, Principal Consultant, BusinessAssociar…
Healthcare industry reports 58 deals worth $12.4 bn in Dec’19
According to GlobalData, three big ticket deals together contributed 63 per cent to the total deal value in the month
E-pharmacies – what lies ahead?
Dr Vikram A Munshi, Founder, WhiteSpace, Consulting and Capability Building discusses how
e-pharmacies are faring in current…
Express Pharma January 16-31, 2020
India's Foremost Pharma & Biotech Magazine ~ Rare Diseases: Awaiting Renewed Focus